Contact

Root Meridian Home About Services Safety & Risks How Ibogaine Works Legal & Access Guide Contact Evidence, uncertainty, and safety Ibogaine Treatment Ibogaine is a plant-derived psychoactive compound receiving renewed attention for opioid withdrawal and addiction, while questions about evidence, legal status, and serious safety risks remain central. A careful distinction: research interest is not the same as established care. Starting with the basics What ibogaine is—and what it is not Ibogaine is a psychoactive alkaloid found in the root bark of Tabernanthe iboga , a plant with traditional spiritual contexts in Central and West Africa. The botanical background of Tabernanthe iboga helps place the compound in its cultural context, rather than treating it as a new or context-free intervention. In the United States, ibogaine is not FDA-approved and remains a Schedule I controlled substance under federal law. The DEA’s explanation of drug scheduling describes the legal framework that shapes access and research in the country. Research focus Interest centers mainly on opioid withdrawal and opioid use disorder, with exploratory work involving PTSD, depression, anxiety, alcohol use, stimulants, and traumatic brain injury. Evidence gap The literature is largely observational, retrospective, or preclinical. Research interest should not be interpreted as clinically confirmed efficacy. High-stakes safety Cardiac rhythm problems, vomiting, seizures, and breathing concerns mean that safety questions are not secondary to discussions of possible benefit. A compound’s origin does not resolve the separate questions of evidence, safety, or legal status. How treatment is discussed A promising idea, not a settled process Some accounts describe ibogaine as a way to reduce acute withdrawal and curb cravings, but these claims require careful interpretation. An overview of ibogaine’s claimed effects on withdrawal and cravings reflects why the topic draws attention while also under

Contact

A quiet place for feedback.